Table 3.
Pre-procedural evaluation |
---|
3D assessment of MV anatomy and identification of leaflet abnormalities |
Measurement of 3D VCA, location of the regurgitant orifice and identification of multiple MR jets |
Favorable echocardiographic features |
A2/P2 prolapse |
Flail gap <10 mm and flail width <15 mm |
Non-tethered leaflets with leaflet length ≥10 mm |
MV area >4 cm2 and baseline MV mean gradient <3 mmHg |
Single central jet or jet has a dominant central location |
Transseptal crossing height to MA plane >4 cm |
Challenging echocardiographic features |
Barlow's disease |
Commissural or anterior leaflet prolapse |
Multisegmented prolapse/flail |
Significant cleft; leaflet or chordal calcification within the grasping zone; |
leaflet perforation |
Severe MA calcification, with <5 mm of leaflet available for grasp |
Posterior mitral leaflet length <7 mm |
MV area <4 cm2 and baseline MV mean gradient 4–5 mmHg |
Small LA size |
Intraprocedural guidance |
Safe and optimal site of transseptal puncture |
Introduction of the steerable guide catheter into the LA and advancement of the clip delivery system |
Safe steering of the clip delivery system and its alignment perpendicular to the MV coaptation plane |
Adequate grasping of the leaflets |
Assessment of MR reduction (3D VCA), device release and exclusion of significant mitral stenosis (3D TEE MV area) |
3D, three-dimensional; LA, left atrium; MA, mitral annulus; MR, mitral regurgitation; MV, mitral valve; VCA, vena contracta area.